Hepatitis C virus (HCV) core protein is essential for virus particle formation. Using HCV core-expressing and non-expressing Huh7 cell lines, Uc39-6 and Uc321, respectively, we performed comparative proteomic studies of proteins in the 0.5% Triton X-100-insoluble fractions of cells, and found that core-expressing Uc39-6 cells had much lower vimentin content than Uc321 cells. In experiments using vimentin-overexpressing and vimentin-knocked-down cells, we demonstrated that core protein levels were affected by cellular vimentin content. When vimentin expression was knocked-down, there was no difference in mRNA level of core protein; but proteasome-dependent degradation of the core protein was strongly reduced. These findings suggest that the turnover rate of core protein is regulated by cellular vimentin content. HCV production was also affected by cellular vimentin content. Our findings together suggest that modulation of hepatic vimentin expression might enable the control of HCV production.
Introduction
Hepatitis C virus (HCV) is a major causative agent of chronic hepatitis Kuo et al., 1989) . Persistent HCV infection, which develops in at least 70% of infected patients, is strongly correlated with the development of severe liver diseases such as fibrosis, steatosis, cirrhosis, and hepatocellular carcinomas (HCC). Since more than 170 million people in the world are currently infected with HCV and there is no treatment completely effective in curing HCV, HCV infection is one of the most important global public health issues. Understanding of the life cycle of HCV and the mechanism by which HCV induces serious liver diseases is crucial for the development of novel anti-HCV strategies.
HCV is an RNA virus of the Flaviviridae family and possesses a singlestranded, positive-sense RNA genome of ∼9.6 kb (Bartenschlager and Lohmann, 2000) . The HCV RNA genome encodes a polyprotein of ∼3000 amino acids that is processed by host and viral proteases into 10 individual components including 4 structural and 6 nonstructural proteins (reviewed by Reed and Rice, 2000) . HCV core protein is crucial for virus particle production as the structural component of the viral nucleocapsid and as a unit required for formation of the active HCV replication/assembly complex in host cells (Boulant et al., 2007; Miyanari et al., 2007) . In addition, the core protein plays pivotal roles in the pathogenesis of HCV infection, as suggested by the finding that transgenic mice expressing core protein in the liver tend to develop liver steatosis with subsequent HCC (Moriya et al., 1998; Moriya et al., 1997) . A large number of studies have revealed that a variety of host proteins interact with the core protein . Although these interactions can markedly affect various biological functions in host cells, it is not clearly known yet which interactions and molecules play roles in HCV production or its pathogenicity. Recent exhaustive gene-silencing analyses of host factors using RNAi demonstrated that RNA helicase DDX3, one of the proteins that interacts with the core, is required for HCV RNA replication as well as HCV production (Ariumi et al., 2007; Randall et al., 2007) .
In host hepatic cells, HCV core protein is distributed preferentially in the detergent-resistant fractions (Matto et al., 2004) , and HCV RNA replication also occurs on detergent-resistant membranes (Aizaki et al., 2004; Shi et al., 2003) , suggesting that host factors in the detergent-resistant fractions play roles in core protein functions. In this study, we focused on HCV core protein and the detergentinsoluble proteins of host cells, and performed comparative targeted proteomic analysis of the detergent-insoluble proteins in HCV coreexpressing and non-expressing hepatic cells. We identified vimentin as a protein the amount of which was reduced in core-expressing cell lines, and demonstrated that cellular vimentin content affects levels of HCV core protein through the proteasome-mediated protein Virology 383 (2009) [319] [320] [321] [322] [323] [324] [325] [326] [327] degradation system. Since cellular vimentin levels ultimately affected HCV production, vimentin may be a novel target for strategies of anti-HCV treatment.
Results
Proteomic analysis of detergent-insoluble fractions (DISFs) by second-dimensional polyacrylamide gel electrophoresis (2D-PAGE)/MALDI-QIT-TOF MS DISFs and detergent-soluble fractions (DSFs) were prepared from HCV core-expressing Uc39-6 and non-expressing Uc321 cells by a sucrose density gradient ultracentrifugation method as described in Materials and methods. Proteins in the DISFs and DSFs were analyzed by immunoblotting with antibodies to HCV core protein and various organelle markers ( Fig. 1A) . A significant amount of HCV core protein (∼ 70%) was distributed in the DISF of Uc39-6 cells. Nuclear proteins such as laminA/C and laminB were concentrated only in the DISFs of both types of cells, whereas other organelle proteins such as annexin II (plasma membrane), fatty acid synthase (cytosol), prohibitin (mitochondria), and calnexin (endoplasmic reticulum) were detected in the DSFs but not DISFs ( Fig. 1A ), suggesting that the DISFs in both types of cells contain minor (∼ 15%) discrete populations of cellular proteins. Next, we performed 2D-PAGE analysis of the DISFs in Uc321 and Uc39-6 cells. Proteins in the DISFs were separated by isoelectric focusing (IEF) (pH 4-7) and 12% sodium dodecyl sulfate (SDS)-PAGE, and visualized by SYPRO-Ruby staining (Fig. 1B) . Intensity of each spot in 2-D images was compared between Uc321 and Uc39-6 cells. The most difference in DISF proteins between Uc321 and Uc39-6 cells (the Uc39-6/Uc321 ratios of intensity normalized with actin: 10.8-28.0) was detected in the spots numbered as 1 in Fig. 1B (MW ∼ 57 kDa, pI ∼ 4.7), in which vimentin alone was identified by mass spectrometric analysis. We therefore focused on the relationship between cellular vimentin and core protein in further investigations. , DSFs (50 μg of protein), and DISFs (5 μg of protein) from core-expressing Uc39-6 and non-expressing Uc321 cells were analyzed by immunoblotting with antibodies to HCV core protein and various organelle markers as indicated. (B) 2D-PAGE analysis of proteins in DISFs of Uc321 and Uc39-6 cells. Proteins (150 μg) were separated by IEF (pH 4-7), followed by SDS-PAGE on a 12% gel. The gels were stained with SYPRO-Ruby. Major spots, identified as cytoskeletal proteins, are marked: 1, vimentin; 2, cytokeratin 8; 3, cytokeratin 18; 4, actin. ⁎: a non-specific spot.
HCV core-expressing cell lines exhibited reduced vimentin content To confirm the reduction of vimentin levels in DISFs of HCV coreexpressing Uc39-6 cells, immunoblot analysis was performed using anti-vimentin antibody. Uc39-6 cells exhibited lower vimentin contents not only in DISF but also the total cell lysate fraction compared with control Uc321 cells ( Fig. 2A) . Similar results were obtained in the cell lysate fraction of another independent clone of an HCV core-expressing Huh7 cell line, Uc39-2 ( Fig. 2B ). Furthermore, a core-expressing hepatic HepG2 cell line, Hep39, also had lower vimentin content than a control cell line, Hepswx (Fig. 2C) . These findings exclude the possibility that the reduction of vimentin levels in core-expressing cell lines is a clone-or cell-specific event. Consistent with these findings, levels of vimentin mRNA in Uc39-2 and Uc39-6 cells were also lower than that in Uc321 cells (data not shown). Taken together, these findings demonstrate marked reduction of vimentin expression in HCV core-expressing cell lines.
Cellular vimentin content affects the protein level of HCV core protein
To investigate the relationship between HCV core protein and vimentin, we examined the effect of cellular vimentin content on level of HCV core protein. When the expression of vimentin or control hypoxanthine guanine phosphoribosyltransferase 1 (HPRT) was knocked down in Uc39-6 cells by siRNA treatment, the protein level of HCV core protein in vimentin-knocked-down cells was significantly higher than those in siRNA-untreated and HPRT-knocked-down cells (Fig. 3A ). On the other hand, cellular mRNA levels of HCV core protein, corrected for β-actin mRNA content, did not differ substantially among these types of cells (Table 1 ). These findings revealed that posttranslational steps were involved in the increase of HCV core protein level in vimentin-knocked-down cells. Next, we established a vimentin-overexpressing Huh7 cell line, Huh7/vimentin, and compared the level of the core protein in Huh7/vimentin cells with that in control Huh7/hygro cells after transient expression of the core protein with pcEF39neo vector. After 9-day culture with G418 selection, the viabilities of the two types of cells were similar, though the level of expression of the core protein in Huh7/vimentin was significantly lower than that in Huh7/hygro cells (Fig. 3B ). These findings demonstrated that level of HCV core protein was inversely correlated with cellular vimentin content, and thus strongly suggested that it was affected by cellular vimentin content.
We further attempted to verify these effects of vimentin using the vimentin-null cell line 1HF5 and the vimentin-expressing control cell line 2CB5, derived from human adrenal carcinoma SW13 cells (Sarria et al., 1990) . When 1HF5 and 2CB5 cells were transfected with the core expression vector pcEF39neo and cultured with G418 selection, the viabilities of the two types of cells were similar, though the level of expression of the core protein in 1HF5 cells was much higher than that in 2CB5 cells ( Fig. 3C ), consistent with the results in Figs. 3A, B. An exogenously vimentin-expressing 1HF5 cell line carrying pcDNA3.1/ Hygro/vimentin, 1HF5/vimentin, and a control vimentin-null cell line carrying pcDNA3.1/Hygro, 1HF5/hygro, were then established, and transfected with the green fluorescent protein (GFP)-expressing pcDNA3.1/EGFP vector, the core-coding pcEF39neo vector, or the control pcFE321swxneo vector. After selection under G418 for 9 days, the viabilities of these transfected cells were nearly the same. The levels of expression of GFP were similar in 1HF5/hygro and 1HF5/ vimentin cells, while the core protein level in 1HF5/vimentin cells was significantly lower than that in 1HF5/hygro cells ( Fig. 3D) , consistent with the results in Fig. 3B .
These findings together indicate that cellular vimentin content regulates the level of HCV core protein in post-translational fashion.
Vimentin is involved in proteasomal degradation of core proteins in cells HCV core proteins are known to be preferentially degraded by the proteasome-dependent pathway (Suzuki et al., 2001) . To determine whether cellular vimentin content affects proteasome-dependent degradation of the core protein, we examined the effects of the proteasome inhibitor MG132 on core protein levels in vimentinknocked-down cells. After Huh7 cells transfected with pCAG/Flag-core (Huh7/Flag-core cells) had been treated with MG132 for 16 h, cellular accumulation of core protein was analyzed by immunoblot ( Fig. 4 ; lanes 3 vs 4), which indicated substantial proteasomal degradation of the core proteins in cultured cells, as described previously (Hope and McLauchlan, 2000; McLauchlan et al., 2002; Suzuki et al., 2001) . Huh7/Flag-core cells transfected with control and HPRT siRNA duplexes exhibited similar increases in core protein levels by treatment with MG132 ( Fig. 4 ; lanes 5 vs 6, and 9 vs 10). On the other hand, vimentin-knocked-down Huh7/Flag-core cells that were transfected with vimentin siRNA duplexes exhibited higher content of core protein (lane 7) than the other siRNA-treated cells (lanes 5 and 9), and MG132 treatment resulted in no significant difference in core protein levels in vimentin-knocked-down cells (lanes 7 and 8), indicating that proteasomal degradation of core proteins was markedly inhibited in the vimentin-knocked-down cells. These observations strongly suggested that vimentin plays an important role in the proteasome-mediated proteolytic pathway of the HCV core protein. Under the various siRNA-treated conditions in Fig. 4 , we also examined the protein levels of p53, one of the endogeneous host proteins the degradation of which is mainly regulated by proteasomal system (Morimoto et al., 2008) . The pattern of p53 protein levels was very similar to that of core protein levels ( Fig. 4 ), suggesting that the vimentin-dependent proteasomal degradation is not specific for the viral core protein. Vimentin-dependent proteasomal degradation system might be generally important for the turnover of endogeneous cellular proteins as well as the viral core protein.
Cellular vimentin contents affect HCV production
Since the level of expression of HCV core protein was affected by cellular vimentin content, we examined whether HCV production was also affected by cellular vimentin content. Infectious HCV (JFH1 strain) particles were used for the following infection assays. HCV production activity was determined by quantification of HCV core protein levels in the infected cells and culture supernatants. We first tested the effect of vimentin knockdown on HCV production. Examination of HCV-infected Huh7 cells treated with vimentin siRNA revealed higher amounts of HCV core protein in both cells and culture medium than examination of non-treated and control HPRT siRNA-treated cells (Fig. 5A ). To examine whether the core protein levels in the cell-cultured media reflect the content of infectious HCV particles in them, Huh7 cells were treated with cell-cultured medium containing equal amounts (1.4 fmol) of the core protein collected from each type of cell described in Fig. 5A , and cellular levels of production of the core protein were determined by immunoblot analysis. They were nearly the same among the cells treated with each culture medium (Fig. 5B ). These findings indicated that reduction of vimentin expression in Huh7 cells leads to more active HCV production and enhanced release to the supernatant.
We next examined the effects of vimentin overexpression on HCV production. When vimentin-overexpressing Huh7/vimentin and control Huh7/hygro cells were infected with HCV particles, Huh7/ vimentin cells exhibited lower amounts of intracellular and extracellular HCV core protein than Huh7/hygro cells ( Fig. 5C ). Consistent with the results in Fig. 5A , these findings suggested that higher expression of vimentin in host cells resulted in lower HCV production.
We also examined the effect of vimentin knockdown on HCV RNA replication using a JFH1-subgenomic replicon (Fig. 5D ). There were no significant differences in replication activities between vimentinknocked-down cells and the other control cells. These findings indicated that cellular level of vimentin has no effects on HCV nonstructural proteins which serve as a unit of RNA replication machinery of HCV. Collectively, these results demonstrated that HCV production activity but not HCV-RNA replication was inversely correlated with cellular vimentin content. with the core protein-expression vector pcEF39neo, and selected under 1 mg/ml of G418 for 9 days. (C) The 2CB5 (vimentin+) and 1HF5 (vimentin−) lines of SW13 cells were transfected with pcEF39neo, and selected under 1 mg/ml of G418 for a week, followed by additional 2-week culture in normal culture medium. (D) 1HF5/hygro and 1HF5/ vimentin cells were transfected with pcDNA3.1/EGFP (GFP), pcFE321swxneo (321), or pcEF39neo (39), and selected under 1 mg/ml of G418 for 9 days. Table 1 mRNA levels of HCV core protein and β-actin in vimentin-knocked-down Uc39-6 cells siRNA -
HPRT vimentin HCV core (× 10 4 copies/μg total RNA) 2.9 ± 0.3 1.7 ± 0.1 3.0 ± 0.2 β-actin (× 10 7 copies/μg total RNA) 3.0 ± 0.1 1.4 ± 0.1 2.3 ± 0.0 HCV core/β-actin a 1 1.3 1.3
Total RNA was isolated from Uc39-6 cells that had been treated twice with a 2-day interval with HPRT siRNA duplexes, with vimentin siRNA duplexes or without (−) either of them, and cultured for 4 days. mRNA levels of HCV core protein and β-actin (a control housekeeping gene) were determined by quantitative real-time PCR. Values are the mean ± SD for three determinations. a Numbers represent the relative amounts of HCV core protein mRNA normalized to β-actin level.
Furthermore, expression of vimentin and HCV core protein in Huh7 cells after HCV infection was observed by immunofluorescence microscopy (Fig. 5E ), and the fluorescent intensity of vimentin in core-positive and core-negative Huh7 cells under HCV-infected conditions was determined (Fig. 5F ). HCV-infected cells stained with the core-specific antibody always had lower vimentin content (Figs. 5E, F). Moreover, as shown in Fig. 5F , HCV core-negative cells exhibited more variable vimentin levels, whereas the core-positive cells had vimentin levels within a narrow range. These observations, which showed that a Huh7 cell population with lower vimentin content can preferentially produce HCV, were consistent with the results shown in Figs. 5A, C.
Finally, we examined the effects of MG132 on HCV core protein levels in HCV-infected cells in which vimentin was knocked-down or overexpressed. In the presence of MG132, non-treated and control HPRT siRNA-treated cells showed the significant increase of cellular HCV core protein levels, whereas vimentin-knocked-down cells did not (Fig. 5G) . These results were consistent with those using HCV core-expressing cells (Fig. 4 ). HCV core content in vimentinoverexpressing Huh7/vimentin cells was lower than that in control Huh7/hygro cells, but after MG132 treatment Huh7/vimentin and Huh7/hygro cells showed the similar HCV core protein levels (Fig.  5H) . Taken together, these results demonstrated the significant involvement of vimentin in proteasome-dependent degradation of HCV core protein in HCV-infected cells (Figs. 5G, H) , as well as in HCV core-expressing cells (Fig. 4) .
Discussion
By comparative proteomic analysis of the detergent-insoluble proteins in HCV core-expressing and non-expressing Huh7 cell lines, vimentin, an intermediate filament protein, was identified as the protein with the most dramatic reduction in level in the detergentinsoluble fraction of HCV core-expressing Uc39-6 cells ( Figs. 1B and 2) . On the other hand, there were no significant differences in the amounts of other major proteins including cytoskeletal components such as actin and cytokeratin 8/18 in the detergent-insoluble fractions between the core-expressing and non-expressing cells (Fig. 1B) . These findings, together with similar results for other core-expressing cells (Fig. 2) , suggested the existence of a specific relationship between the core protein and cellular vimentin. Consistent with these findings, immunofluorescence microscopic analysis of core-expressing cells (data not shown) and HCV-infected cells (Figs. 5E, F) showed that cells with intrinsic lower amount of vimentin are more permissive for higher HCV core protein content.
Knockdown of vimentin expression by siRNA treatment resulted in an increase in HCV core protein levels (Fig. 3A) , while overexpression of vimentin reduced core protein contents (Fig. 3B) . Similar results were obtained in the experiments using the vimentin-null cell line 1HF5 derived from SW13 cells ( Figs. 3C and D) . On the other hand, transient knockdown and overexpression of the core proteins in Uc39-6 and Huh7 cells, respectively, did not result in differences in cellular vimentin content (data not shown). These findings indicated that cellular vimentin level affects the level of expression of the core protein but not vice versa. Although transient expression of the core protein did not affect cellular vimentin content, why do various stable cell lines expressing the core protein have lower vimentin level? Since it was very hard to establish the cells stably expressing the core protein, we speculate that only the minor cell population innately having lower vimentin content was able to maintain the substantial core expression levels and was therefore selected.
We next demonstrated that vimentin affects core protein levels in post-translational fashion (Table 1) and is required for the proteasomal degradation of core protein in core-expressing cells (Fig. 4) and also in HCV-infected cells (Figs. 5G, H) . Many studies with proteasome inhibitors have shown that a major pathway of degradation of core protein is mediated by the proteasomal system (Hope and McLauchlan, 2000; McLauchlan et al., 2002; Moriishi et al., 2003; Suzuki et al., 2001) . PA28γ, a REG family proteasome activator also known as REGγ and Ki antigen, which is located in the nucleus, was shown to play an important role in the proteasomal degradation of the core protein (Moriishi et al., 2003) . It was recently reported that the ubiquitin ligase E6AP, which is distributed in the perinuclear cytoplasm and colocalized with the core protein, is also involved in ubiquitylation and degradation of core protein (Shirakura et al., 2007) . Vimentin filaments extend from the nuclear membrane toward the cell periphery. In addition, vimentin is known to colocalize with ubiquitinated protein aggregates and form aggresomes when the capacity of the proteasome is exceeded (Johnston et al., 1998) . Pull-down assays against the core protein in coreexpressing Huh7 cells indicated that a minor portion of cellular vimentin can interact with HCV core protein (data not shown), as Fig. 4 . Effects of the proteasome inhibitor MG132 on level of expression of HCV core protein in Huh7 cells. siRNA duplexes of control, HPRT, or vimentin, together with the core protein-expression vector pCAG/Flag-core, were transfected into Huh7 cells. After 2 days, transfection of these siRNAs was repeated. Cells were further cultured for 2 days and treated with (+) or without (−) MG132 (50 μM) for 16 h. Equivalent amounts of cell lysates were analyzed by immunoblotting with antibodies to vimentin, HPRT, core protein, p53, and GAPDH. Kang et al. had reported previously (Kang et al., 2005) . Co-staining of cellular vimentin and the core protein on immunofluorescence microscopy also supported the existence of a minor but definite association between them (data not shown). Based on these findings, we speculate that vimentin plays a role in the transport of the core protein to the nucleus, where it is then degraded, although further biochemical studies will be needed to demonstrate this.
HCV core protein is distributed mainly in the ER and lipid droplets in host cells (Barba et al.,1997) , and the ER membrane associating the lipid droplets with core protein has been recognized as a site important for HCV production, particularly HCV RNA replication and virus particle assembly (Boulant et al., 2007; Miyanari et al., 2007) . Vimentin is also closely associated with lipid droplets (Brasaemle et al., 2004; Lieber and Evans, 1996; Schweitzer and Evans, 1998) . Thus, in addition to its degradative modulation of core protein, vimentin might also affect the function of lipid droplets and consequently inhibit HCV production. The effects of vimentin knock-down and overexpression on HCV production were actually stronger at the extracellular core protein level (secretion of the virus) than at the intracellular core protein level (Figs. 5A, C) , suggesting additional activity of vimentin in the processes of HCV particle release.
Since the level of expression of vimentin in carcinomas is correlated with parameters of malignant potential such as tumor grade and tumor invasion, vimentin has been used as a marker of malignant tumors (Bannasch et al., 1982) . It has indeed been reported that some HCV-infected patients with hepatocellular carcinoma exhibited up-regulation of vimentin expression in tumor tissue (Kim et al., 2003) although further statistical studies are required to clearly demonstrate this. Tanaka et al. noted that in livers of HCV-infected patients with hepatocelllular carcinoma the virus existed predominantly in non-cancerous tissue, at levels 10-to 100-fold higher than in cancerous tissue (Tanaka et al., 2004) . These observations in human liver samples suggest that the reduction in HCV levels in hepatic tumor can be explained by the increase of vimentin expression in tumor, consistent with our findings for cultured cells.
In this study we demonstrated that cellular vimentin expression enhanced the proteasomal degradation of core protein and eventually restricted HCV production. Vimentin itself and sites of vimentin/core interaction may thus be novel targets of treatment using anti-HCV strategies.
Materials and methods

Antibodies
Mouse monoclonal antibodies to annexin II, fatty acid synthase, calnexin, lamin A/C, and GFP were purchased from BD Transduction Laboratories. Mouse monoclonal antibodies to HCV core protein, prohibitin, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were from Anogen, Lab Vision, and Abcam, respectively. Rabbit polyclonal antibodies to vimentin, lamin B1, p53, and HPRT were from Santa Cruz Biotechnology Inc., while those to actin were from Biomedical Technologies Inc.
Plasmids
The mammalian expression vector of HCV core protein, pcEF39neo (Ruggieri et al., 1997) , and the empty vector pcEF321swxneo (Harada et al., 1995) were described previously. The mammalian expression vector of Flag-tagged HCV core protein, pCAG/Flag-core, and the empty vector, pCAG, were described previously (Moriishi et al., 2003) . For construction of a mammalian expression vector of vimentin, pcDNA3.1/Hygro/vimentin, vimentin fragment was amplified by PCR using the reverse-transcribed cDNAs of Huh7 cells as a template. The PCR primer pairs used were 5′-GCCATGTCCACCAGGTCCGTGTCC-3′ and 5′-TTATTATTCAAGGTCATCGTGATG-3′. The PCR products were inserted into the EcoRV site of pBluescript SKII(+). pBluescript SK(+)/vimentin was digested with Hind III and Xba I, and the vimentin fragment was inserted into pcDNA3.1/Hygro (Invitrogen), which had been digested with Hind III and Xba I. For construction of pcDNA3.1/EGFP, EGFP fragment was prepared by digestion of pEGFP-N1 (Clontech Laboratories, Inc.) with Nhe I and Hind III and inserted into pcDNA3.1/Hygro, which had been digested with Nhe I and Hind III. The subgenomic replicon constructs, pSGR-JFH1/Luc (wild type) and pSGR-JFH1/Luc-GND (GND mutation in the NS5B sequence), with the firefly luciferase reporter gene were described previously .
Cell lines
All hepatic cells used in this study were plated on collagen-coated dishes (Asahi Techno Glass, Japan). Human hepatic Huh7 and Huh7.5.1 cells were grown in normal culture medium [Dulbecco's modified Eagle's medium (DMEM) (KOJIN BIO, Japan) supplemented with 10% fetal bovine serum (FBS), 100 U/ml Penicillin G, and 100 mg/ml streptomycin sulfate] containing 0.1 mM non-essential amino acids (GIBCO) under a 5% CO 2 atmosphere at 37°C. We used human hepatic cell lines constitutively expressing HCV core protein, including Hep39 from HepG2 cells (Harada et al., 1995; Ruggieri et al., 1997) and Uc39-2 and Uc39-6 from Huh7 cells Sato et al., 2006) . Huh7 and HepG2 cell lines carrying the empty vector, Hepswx and Uc321, respectively, were used as a mock control. All of these stable transfectants were maintained in normal culture medium containing 1 mg/ml G418 (Sigma). The human adrenal carcinoma cell line SW13, the subtypes 2CB5 and 1HF5 of which do or do not express vimentin, respectively (Sarria et al., 1990) , was maintained in normal culture medium. When the pcDNA3.1/EGFP vector was transfected into 2CB5 and 1HF5 cells, the percentage of GFP-positive cells was 56.3% and 53.6%, respectively, 2 days after transfection (n = 3), indicating that there was no difference in the transfection efficiency between these cells. To establish vimentin-overexpressing cells, pcDNA3.1/Hygro/vimentin was transfected into 1HF5 and Huh7 cells using FuGENE 6 transfection regent (Roche). The vimentin-overexpressing Huh7 and 1HF5 cells were selected under hygromycin for 2 weeks and cloned to obtain Huh7/vimentin cells and 1HF5/vimentin cells, respectively. Huh7 and 1HF5 cells carrying the empty vector pcDNA/Hygro were also established, as Huh7/hygro cells and 1HF5/hygro cells, respectively.
Preparation of DISFs
Confluent monolayers of Uc321 and Uc39 cells in four culture dishes (150 mm inner diameter) were harvested by trypsinization, and 1.5 × 10 7 cells of each were pelleted by centrifugation (218 ×g for 5 min at 4°C). After washing with PBS three times, each cell pellet was resuspended in 1 ml of lysis buffer [10 mM HEPES-HCl, pH 7.5, 10 mM NaCl, 140 mM KCl, 0.5 mM DTT, 0.5% Triton X-100 (Pierce Biotechnology), 10 mM NaF, Complete™ EDTA-free (Roche)] (i.e. a 20% cell suspension). The cell suspension was lysed with a ballbearing homogenizer . The soluble fraction (designated the detergent-soluble fraction, DSF) containing ∼ 85% of the total cellular proteins was collected by centrifugation of the cell Fig. 5 . HCV production in vimentin-knockdown and vimentin-overexpressing Huh7 cells. (A) Huh7 cells (5 × 10 4 cells) in 48-well plates were incubated with or without HCV particles (including 8.0 fmol of core protein) for 6 h, and then treated twice with a 3-day interval without (−) or with siRNA duplexes of HPRT or vimentin. After 7-day culture, the amounts of HCV core protein per cell in cells (light gray bar) and culture medium (dark gray bar) were determined. n = 3. (B) Culture medium was collected at day 6 in the infection experiment described above in (A). The concentration of HCV core protein in these samples of medium was adjusted to 2.7 fmol/ml with fresh medium. Cells were infected with these samples of medium containing 1.4 fmol of HCV core protein for 2 days, and harvested after 7-day incubation. Infectivity was analyzed by the immunoblotting of cell lysates with antibodies to HCV core protein and β-actin. (C) Vimentin-overexpressing Huh7/vimentin and control Huh7/hygro cells infected with HCV were harvested after 7-day incubation. The amounts of HCV core protein per cell in cells (light gray bar) and culture medium (dark gray bar) were determined. (D) Huh7 cells harboring the HCV subgenomic replicon containing a luciferase reporter gene were transfected without (−) or with siRNA duplexes of HPRT or vimentin. After 2.5-day culture, luciferase activity in cell extracts was determined. n = 3. (E) Immunofluorescence microscopic analysis of HCV-infected Huh7 cells. After infection with HCV, Huh7 cells were cultured for 6 days. HCV core protein (green) and vimentin (red) were then detected with specific antibodies. Nuclei (blue) were stained with DAPI. Two views showing low and high magnifications are displayed. Bars, 100 μm in the left panel; 50 μm in the right panel. (F) Under the HCV-infected conditions in panel E, fluorescence intensity of vimentin in core-positive and core-negative Huh7 cells was determined by line profile analysis. n = 40. Statistical significance of differences in fluorescence intensity of vimentin between core-positive and core-negative cells was evaluated using Student's t test, showing p b 10 − 8 . (G) As in (A), Huh7 cells were incubated with HCV particles, and then treated twice with a 2-day interval without (−) or with siRNA duplexes of HPRT or vimentin. After 4.5-day culture, cells were treated with (+) or without (−) MG132 (50 μM) for 16 h. In each culture condition, the ratio of HCV core protein level in the MG132-treated cells to that in MG132-untreated cells was determined. n = 3. (H) Huh7/vimentin and Huh7/hygro cells infected with HCV were cultured for 4 days and treated with (+) or without (−) MG132 (50 μM) for 16 h. The amounts of cellular core protein per cell were determined. n =3. lysate performed twice at 218 ×g for 5 min at 4°C. The insoluble pellet was suspended in 2 ml of lysis buffer containing 1.62 M sucrose and then centrifuged at 10,000 ×g for 1 h at 4°C. The pellet was resuspended in 1 ml of lysis buffer containing 1.0 M sucrose and layered over 2 ml of lysis buffer containing 2.0 M sucrose. After centrifugation at 50,000 ×g for 2 h at 4°C, the precipitated fraction containing ∼ 15% of total cellular proteins was collected and resuspended in lysis buffer containing 0.25 M sucrose at a concentration of 3 mg protein/ml (designated the detergent-insoluble fraction, DISF). Each fraction was stored at −80°C until use. The protein concentrations in these preparations were determined with BCA protein assay reagents (Pierce Biotechnology) using BSA as a standard.
2D-PAGE/MALDI-QIT-TOF MS analysis
The DISF (0.15 mg protein) of each cell line was cleaned using a PlusOne ™ 2-D Clean Up kit (GE Healthcare) and resuspended in rehydration solution containing 9 M urea, 4% CHAPS, 65 mM dithioerythritol, and 0.5% ampholyte. The first-dimensional IEF was performed with an Immobiline Dry Strip pH 4-7 according to the manufacturer's instruction (GE Healthcare). The second-dimensional electrophoresis was carried out on 12% SDS-polyacrylamide gel, and the gel was stained with SYPRO-Ruby (Bio-Rad). Spot detection and comparison in 2D images were accomplished with PDQuest ™ 2-D analysis software ver. 7.3 (Bio-Rad). The protein bands were excised from the gel and subjected to in-gel trypsin digestion. The tryptic peptide mixtures were analyzed by MALDI-QIT-TOF MS (AXIMA-QIT, Shimazu Biotech, Japan) as described previously Shevchenko et al., 1996) . Mascot software (Matrix Science) was used for protein identification.
Immunoblot analysis
The proteins were separated by electrophoresis in precast NuPAGE 10% or 12% Bis-Tris gels (Invitrogen), and then transferred to a polyvinylidene difluoride membrane. The membranes were blocked overnight at 4°C or for 60 min at room temperature in Tris-buffered saline containing 0.1% Tween 20 and 5% skim milk. The blots were probed with the first antibodies at 1:1000 dilution for 60 min at room temperature and then incubated with horseradish peroxidase (HRP)conjugated goat anti-rabbit IgG (Bio-Rad) or HRP-conjugated goat anti-mouse IgG (GE Healthcare) at 1:2000 dilution for 45 min. Detection of immunoreactive proteins was performed using an ECL system (GE Healthcare).
Quantitative real-time PCR analysis
Cellular total RNAs were prepared with an RNeasy kit (Qiagen). The total RNA fraction (1 μg) was processed directly to cDNA using a Transcriptor First Strand cDNA Synthesis Kit (Roche). Of the total 20 μl cDNA solution, an aliquot of 0.5-2 μl was used for each real-time PCR assay. The PCR primers used for HCV core protein were: forward, 5′-AGGAAGACTTCCGAGCG-3′, and reverse, 5′-GGGTGACAGGAGCCATC-3′. The PCR primers for actin were obtained from the LightCycler ™ -Primer Set (Roche). Quantitative real-time PCR was carried out in a LightCycler (Roche) using LightCycler-FastStart DNA Master SYBR Green I (Roche).
Transfection of siRNA
Subconfluent cells cultured in a 48-well plate were transfected twice at a 2-or 3-day interval with 30 nM of vimentin-specific, HPRTspecific, or negative control (Invitrogen) siRNA duplexes using Lipofectamine RNAiMAX (Invitrogen) following the manufacturer's instructions. The siRNA target sequences were as follows: vimentin (sense), 5′-ACCTTGAACGCAAAGTGGAATCTTT-3′; HPRT-S1 (sense), 5′-AAGCCAGACUUUGUUGGAUUUGAAA-3′.
Infection of Huh7 cells with HCV
Infectious HCV (JFH1 strain) particles were produced in Huh7.5.1 cells as described previously . Culture supernatant containing infectious HCV particles was collected and stored at −80°C until use. Subconfluent naïve Huh7, Huh7/hygro, or Huh7/vimentin cells in 24-well or 48-well plates were exposed to normal culture medium containing HCV particles (1.4-8 fmol core protein/well, corresponding to moi = 0.0175-0.1) for 6 h at 37°C. Cells were then washed and maintained in 500 μl (24-well) or 250 μl (48-well) of normal culture medium for 6-7 days at 37°C. To determine HCV production activity, the amounts of HCV core protein in the culture medium and cell lysates were quantified with an enzyme-linked immunosorbent assay (ELISA) (Ortho ® HCV antigen ELISA test, Ortho-Clinical Diagnostics, Japan).
Assay for activity of HCV genomic RNA replication
The RNAs (30 μg) transcribed from pSGR-JFH1/Luc and pSGR-JFH1/ Luc-GND were transfected into Huh7 cells (1.6 × 10 6 cells) by electroporation. Transfected cells in normal culture medium were immediately seeded into 48-well plates at 9.0 × 10 4 cells/well. Four hours after transfection, siRNAs were also transfected into these cells. After incubation for 2.5 days, cells were harvested and the luciferase activity in cell lysates was determined with the Luciferase Assay System (Promega). Since the luciferase activities of the JFH1/Luc replicon were ∼400-fold higher than those of the JFH1/Luc-GND mutant replicon, background luciferase activity, which is independent of replication activity, was very low in our experimental conditions.
Immunofluorescence microscopy
Cells cultured on glass cover slips (in 24-well plates) were fixed in 1% formaldehyde-PBS for 1 h at 4°C, permeabilized in PBS containing 0.1% Triton X-100 for 5 min, and washed twice with PBS. The cell monolayers were incubated with rabbit anti-vimentin antibodies (1:100) and mouse anti-HCV core protein antibodies (1: 100) for 60 min at room temperature. After washing with PBS, the cells were incubated with Alexa488-conjugated anti-mouse IgG, Alexa594-conjugated anti-rabbit IgG, and DAPI (4′, 6′-diamidino-2phenylindole) (Invitrogen) for 60 min at 4°C. Coverslips were washed with PBS and mounted on glass slides. Immunofluorescence was visualized and quantitated with a confocal laser-scanning microscope (Axiovert 100M, Carl Zeiss) equipped with a LSM510 system (Carl Zeiss).
